OnabotulinumtoxinA: A Review in the Prevention of Chronic Migraine (vol 78, pg 589, 2018)

被引：2
|
作者：
Frampton, James E. [1 ]
Silberstein, Stephen [2 ]
机构：
[1] Springer, Private Bag 65901, Auckland 0754, New Zealand
[2] Jefferson Headache Ctr, Philadelphia, PA USA
来源：
DRUGS | 2018年 / 78卷 / 06期
关键词：
D O I：
10.1007/s40265-018-0906-6
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
The article OnabotulinumtoxinA: A Review in the Prevention of Chronic Migraine, written by James E. Frampton and Stephen Silberstein, was originally published Online First without open access. After publication in volume 78, issue 5, pages 589–600 [funder] requested that the article be Open Choice to make the article an open access publication. Post-publication open access was funded by [funder]. Further details may be found at [MedEngine webpage link].
引用
收藏
页码：715 / 715
页数：1
相关论文
共 50 条
  • [1] OnabotulinumtoxinA: A Review in the Prevention of Chronic Migraine
    Frampton, James E.
    Silberstein, Stephen
    DRUGS, 2018, 78 (05) : 589 - 600
  • [2] OnabotulinumtoxinA: A Review in the Prevention of Chronic Migraine
    James E. Frampton
    Stephen Silberstein
    Drugs, 2018, 78 : 589 - 600
  • [3] Correction to: OnabotulinumtoxinA: A Review in the Prevention of Chronic Migraine
    James E. Frampton
    Stephen Silberstein
    Drugs, 2018, 78 : 715 - 715
  • [4] OnabotulinumtoxinA for the Prevention of Chronic Migraine in Adults
    Savoy, Margot
    AMERICAN FAMILY PHYSICIAN, 2020, 101 (03) : 144 - 145
  • [5] Evaluation of OnabotulinumtoxinA Treatment in Patients with Concomitant Chronic Migraine and Temporomandibular Disorders (vol 55, pg 330, 2018)
    Kocaman, Gulsen
    Kahraman, Nese
    Gurkan Koseoglu, Banu
    Bilgic, Basar
    Matur, Zeliha
    Ertas, Mustafa
    Gulsen, Yesim
    Baykan, Betul
    NOROPSIKIYATRI ARSIVI-ARCHIVES OF NEUROPSYCHIATRY, 2019, 56 (01): : 83 - 83
  • [6] OnabotulinumtoxinA in Chronic Migraine: A Profile of Its Use (vol 34, pg 1287, 2020)
    Frampton, James E.
    CNS DRUGS, 2021, 35 (06) : 701 - 701
  • [7] Effect of OnabotulinumtoxinA Injection on Depression in Chronic Migraine (vol 55, pg 1218, 2015)
    Maasumi, K.
    Thompson, N. R.
    Kriegler, J. S.
    Tepper, S. J.
    HEADACHE, 2016, 56 (02): : 449 - 449
  • [8] OnabotulinumtoxinA in Chronic Migraine: A Profile of Its Use (vol 34, pg 1287, 2020)
    Frampton, James E.
    CNS DRUGS, 2021, 35 (01) : 135 - 135
  • [9] Onabotulinumtoxina in the Prevention of Migraine in Pediatric Population: A Systematic Review
    Mavridi, Artemis
    Redmond, Aine
    Archontakis-Barakakis, Paraschos
    Bogdanova-Mihaylova, Petya
    Deligianni, Christina I.
    Mitsikostas, Dimos D.
    Mavridis, Theodoros
    TOXINS, 2024, 16 (07)
  • [10] Mechanism of Action of OnabotulinumtoxinA in Chronic Migraine: A Narrative Review
    Burstein, Rami
    Blumenfeld, Andrew M.
    Silberstein, Stephen D.
    Adams, Aubrey Manack
    Brin, Mitchell F.
    HEADACHE, 2020, 60 (07): : 1259 - 1272
12345